[PHARMA] YoY TTM Result on 30-Sep-2014 [#3]

Stock
[PHARMA] PHARMANIAGA BHD
Announcement Date
21-Nov-2014
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2014
Quarter
30-Sep-2014 [#3]
Profit Trend
QoQ- 16.78%
YoY- 194.71%
Quarter Report
Latest QR
Upcoming QR
PHARMA's Result
PHARMA's Financial Summary
View:
Show?
TTM Result
30/09/17 30/09/16 30/09/15 30/09/14 30/09/13 30/09/12 30/09/11 CAGR
Revenue 2,293,580 2,286,356 2,136,265 2,063,690 1,861,183 1,697,728 1,529,311 6.98%
PBT 57,267 91,665 126,859 120,733 64,238 115,434 54,117 0.94%
Tax -25,268 -28,865 -21,695 -41,862 -36,212 -32,578 -15,466 8.51%
NP 31,999 62,800 105,164 78,871 28,026 82,856 38,651 -3.09%
-
NP to SH 31,187 62,497 104,679 77,960 26,453 81,587 37,959 -3.21%
-
Tax Rate 44.12% 31.49% 17.10% 34.67% 56.37% 28.22% 28.58% -
Total Cost 2,261,581 2,223,556 2,031,101 1,984,819 1,833,157 1,614,872 1,490,660 7.18%
-
Net Worth 531,892 531,250 534,373 507,124 473,402 496,469 464,092 2.29%
Dividend
30/09/17 30/09/16 30/09/15 30/09/14 30/09/13 30/09/12 30/09/11 CAGR
Div 41,490 51,803 90,625 57,457 37,168 64,713 - -
Div Payout % 133.04% 82.89% 86.57% 73.70% 140.51% 79.32% - -
Equity
30/09/17 30/09/16 30/09/15 30/09/14 30/09/13 30/09/12 30/09/11 CAGR
Net Worth 531,892 531,250 534,373 507,124 473,402 496,469 464,092 2.29%
NOSH 259,821 259,146 259,027 258,737 258,689 117,646 106,933 15.93%
Ratio Analysis
30/09/17 30/09/16 30/09/15 30/09/14 30/09/13 30/09/12 30/09/11 CAGR
NP Margin 1.40% 2.75% 4.92% 3.82% 1.51% 4.88% 2.53% -
ROE 5.86% 11.76% 19.59% 15.37% 5.59% 16.43% 8.18% -
Per Share
30/09/17 30/09/16 30/09/15 30/09/14 30/09/13 30/09/12 30/09/11 CAGR
RPS 883.98 882.26 824.73 797.60 719.47 1,443.07 1,430.15 -7.69%
EPS 12.02 24.12 40.41 30.13 10.23 69.35 35.50 -16.50%
DPS 16.00 20.00 35.00 22.20 14.37 55.00 0.00 -
NAPS 2.05 2.05 2.063 1.96 1.83 4.22 4.34 -11.74%
Adjusted Per Share Value based on latest NOSH - 258,737
30/09/17 30/09/16 30/09/15 30/09/14 30/09/13 30/09/12 30/09/11 CAGR
RPS 159.14 158.64 148.23 143.19 129.14 117.80 106.11 6.98%
EPS 2.16 4.34 7.26 5.41 1.84 5.66 2.63 -3.22%
DPS 2.88 3.59 6.29 3.99 2.58 4.49 0.00 -
NAPS 0.3691 0.3686 0.3708 0.3519 0.3285 0.3445 0.322 2.29%
Price Multiplier on Financial Quarter End Date
30/09/17 30/09/16 30/09/15 30/09/14 30/09/13 30/09/12 30/09/11 CAGR
Date 29/09/17 30/09/16 30/09/15 30/09/14 30/09/13 28/09/12 30/09/11 -
Price 4.14 5.58 6.50 4.63 4.82 7.55 5.90 -
P/RPS 0.47 0.63 0.79 0.58 0.67 0.52 0.41 2.30%
P/EPS 34.44 23.14 16.08 15.37 47.14 10.89 16.62 12.89%
EY 2.90 4.32 6.22 6.51 2.12 9.19 6.02 -11.45%
DY 3.86 3.58 5.38 4.79 2.98 7.28 0.00 -
P/NAPS 2.02 2.72 3.15 2.36 2.63 1.79 1.36 6.80%
Price Multiplier on Announcement Date
30/09/17 30/09/16 30/09/15 30/09/14 30/09/13 30/09/12 30/09/11 CAGR
Date 15/11/17 21/11/16 26/11/15 21/11/14 19/11/13 06/11/12 01/11/11 -
Price 3.82 5.70 6.50 4.45 4.72 8.25 5.90 -
P/RPS 0.43 0.65 0.79 0.56 0.66 0.57 0.41 0.79%
P/EPS 31.78 23.64 16.08 14.77 46.16 11.90 16.62 11.39%
EY 3.15 4.23 6.22 6.77 2.17 8.41 6.02 -10.22%
DY 4.19 3.51 5.38 4.99 3.04 6.67 0.00 -
P/NAPS 1.86 2.78 3.15 2.27 2.58 1.95 1.36 5.35%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment